This transition in the sexual health category should continue in 2026, and while this may pressure Subscriber growth in the short-term, getting more Subscribers to use daily sexual health offerings results in better retention, and thus higher-quality, more stable sales growth
Pfizer's danuglipron, once considered the primary competitor, was discontinued in April 2025 after a case of potential drug-induced liver injury in a dose-optimization study, following the earlier termination of lotiglipron in 2023 for similar hepatic concerns
Let's get the bill Before I got on Ozempic, my doctor had tried to put me on Wegovy or Saxenda
What about price and insurance Novo Nordisk has not released a full list price yet, but it is expected to be cheaper than weekly injections
PlexusDx provides ongoing provider support through telehealth check-ins to monitor your progress, manage side effects, and adjust your dose as needed
Sexual dysfunctions induced by stress of timed intercourse and medical treatment